MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Progressive supranuclear palsy(PSP)"

  • 2025 International Congress

    Parkinsonism in Uzbekistan: Clinical and Demographic Insights from 2024

    Y. Nishonova, B. Mukhammedaminov, L. Kenjaeva, N. Aripova (Tashkent, Uzbekistan)

    Objective: We retrospectively analyzed the medical records of all parkinsonism patients admitted to our clinic in 2024, examining neurological, psychiatric, radiological, and demographic characteristics of…
  • 2025 International Congress

    Gait Variability is Associated with Executive Function in Progressive Supranuclear Palsy

    A. D'Souza, C. Sotirakis, J. Fitzgerald, C. Antoniades (Oxford, United Kingdom)

    Objective: This study aims to investigate the relationship between executive function and gait in PSP using clinical assessments and objective gait analysis with wearable sensors.…
  • 2025 International Congress

    Identification of Genetic Variants in Progressive Supranuclear Palsy in China

    Y. Kang, W. Luo (Hangzhou, China)

    Objective: To delineate the genetic landscape of progressive supranuclear palsy (PSP) in Chinese patients.Progressive supranuclear palsy is a neurodegenerative disorder primarily considered sporadic, with MAPT…
  • 2025 International Congress

    Changes in Inhibitory Control Differentiate Progressive Supranuclear Palsy from Early Parkinson’s Disease

    B. Couto, F. Castano, J. Carrillo, M. Roca, A. Chade, O. Gershanik, G. Gomez-Arevalo (Buenos Aires, Argentina)

    Objective: To describe distinct type of errors and frequency of perseverative errors in executive, memory, language, and attentional tasks in PSP and PD. Background: Progressive…
  • 2025 International Congress

    The Sedentary Index (SI) for Daily Life Activity Monitoring in Progressive Supranuclear Palsy (PSP)

    M. Dale, C. Silva-Batista, A. Ragothaman, Z. Nhem, A. Lawston, G. Harker, D. Maxwell, C. Speirs, D. Loudon, M. Mancini (Portland, USA)

    Objective: To confirm the feasibility of daily life physical activity monitoring in PSP using a single activPAL sensor, and to examine preliminary associations between overall…
  • 2025 International Congress

    Clinical Features Suggestive of Alpha-Synucleinopathy in Progressive Supranuclear Palsy

    C. Painous, A. Martínez-Reyes, J. Santamaria, M. Fernández, A. Cámara, Y. Compta (Barcelona, Spain)

    Objective: To compare the presence of symptoms suggestive of synucleinopathy between PSP-parkinsonism (PSP-P), Parkinson's disease (PD) and PSP-Richardson syndrome (PSP-RS). Background: Clinical signs with high…
  • 2025 International Congress

    A Case of Mixed Presentation of 4R Tauopathies

    S. Ghourchian, A. Kay (Brooklyn, USA)

    Objective: To describe the diagnostic challenges, and management of a patient with overlapping features of corticobasal syndrome (CBS) and progressive supranuclear palsy (PSP) Background: CBS…
  • 2025 International Congress

    Plasma tau-species-containing neuron-derived extracellular vesicles as potential biomarkers for progressive supranuclear palsy

    YC. Zheng, HH. Cai, WY. Kou, ZW. Yu, T. Feng (Beijing, China)

    Objective: This study aimed to develop and validate novel plasma PSP biomarkers based on tau-species-containing neuron-derived extracellular vesicles (NDEVs) in two independent cohorts (discovery and…
  • 2025 International Congress

    Clinical Deficits, Quality of Life and Caregiver Burden across PSP Phenotypes

    A. Cámara, I. Zaro, C. Painous, Y. Compta (Barcelona, Spain)

    Objective: To assess clinical deficits, quality of life and caregiver burden across progressive supranuclear palsy (PSP) phenotypes considering also other variables such as age, sex…
  • 2025 International Congress

    Neuropsychiatric profile of progressive supranuclear palsy phenotypes

    V. Martinez-Villota, L. Ortega-Bolaños, M. Rodríguez-Violante (Pasto, Colombia)

    Objective: To analyze neuropsychiatric symptoms among phenotypes of patients with Progressive supranuclear palsy  (PSP) in movement disorder centers in Colombia and Mexico. Background: Progressive supranuclear…
  • 1
  • 2
  • 3
  • …
  • 42
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • #28953 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley